Literature DB >> 3153286

Complications of nephropathic cystinosis after renal failure.

W A Gahl1, M I Kaiser-Kupfer.   

Abstract

Fifteen patients with nephropathic cystinosis, ranging in age from 13 to 27 years, were studied. Two were in renal failure; 13 had functioning renal allografts; 5 had severe, uncorrectable loss of visual acuity as well as posterior synechiae and crystal deposits on the lens surface. All 15 patients had photophobia and corneal erosions to variable degrees. All patients were growth retarded with delayed bone ages. Puberty occurred late, but was generally complete by 17 years of age. Hepatic function appeared normal. Only 1 patient had neurological deterioration, but 11 patients had some degree of cerebral atrophy radiologically. The continued accumulation of cystine within cystinotic tissues results in serious extrarenal complications many years after renal transplantation in cystinosis.

Entities:  

Mesh:

Year:  1987        PMID: 3153286     DOI: 10.1007/bf00849221

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Course of nephropathic cystinosis after age 10 years.

Authors:  W A Gahl; J A Schneider; J G Thoene; R Chesney
Journal:  J Pediatr       Date:  1986-10       Impact factor: 4.406

2.  Hepatotoxicity of cysteamine?

Authors:  W A Gahl; J D Schulman; J G Thoene; J Schneider
Journal:  J Pediatr       Date:  1983-12       Impact factor: 4.406

3.  Nonabsorptive hydrocephalus associated with nephropathic cystinosis.

Authors:  D L Ross; C F Strife; R Towbin; K E Bove
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

4.  Long-term treatment of infantile nephropathic cystinosis with cysteamine.

Authors:  V A da Silva; R P Zurbrügg; P Lavanchy; A Blumberg; H Suter; S R Wyss; C M Lüthy; O H Oetliker
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

5.  Veno-occlusive disease of the liver associated with cysteamine treatment of nephropathic cystinosis.

Authors:  E D Avner; D Ellis; R Jaffe
Journal:  J Pediatr       Date:  1983-05       Impact factor: 4.406

6.  Cystinosis. A clinical, histopathologic, and ultrastructural study.

Authors:  P O Sanderson; T Kuwabara; W J Stark; V G Wong; E M Collins
Journal:  Arch Ophthalmol       Date:  1974-04

7.  Survival time in cystinosis. A collaborative study.

Authors:  N Gretz; F Manz; R Augustin; T M Barrat; C Bender-Götze; M Brandis; H J Bremer; J Brodehl; M Broyer; M Bulla; L Callis; C Chantler; L Diekmann; M J Dillon; F Egli; J H Ehrich; W Endres; A Fanconi; C Feldhoff; J Geisert; D Gekle; B Geschöll-Bauer; K Grote; R Grüttner; W Hagge; C B Haycock; H Hennemann; B Klare; D Leupold; H Löhr; D Michalk; A Oliveira; F Ott; K Pistor; J Rau; K Schärer; F Schindera; H Schmidt; H Schulte-Wissermann; K Verrier-Jones; H P Weber; U Willenbockel; H Wolf
Journal:  Proc Eur Dial Transplant Assoc       Date:  1983

8.  Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?

Authors:  R L Pisoni; J G Thoene; H N Christensen
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

9.  Carnitine deficiency induced during intermittent haemodialysis for renal failure.

Authors:  T Bohmer; H Bergrem; K Eiklid
Journal:  Lancet       Date:  1978-01-21       Impact factor: 79.321

10.  Kidney transplantation in uremic children with cystinosis.

Authors:  R P Langlois; S O'Regan; M Pelletier; P Robitaille
Journal:  Nephron       Date:  1981       Impact factor: 2.847

View more
  18 in total

1.  Visual and verbal learning in a genetic metabolic disorder.

Authors:  Amy M Spilkin; Angela O Ballantyne; Doris A Trauner
Journal:  Neuropsychologia       Date:  2009-03-09       Impact factor: 3.139

2.  Effects of oral phosphocysteamine and rectal cysteamine in cystinosis.

Authors:  W G van't Hoff; T Baker; R N Dalton; L C Duke; S P Smith; C Chantler; G B Haycock
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

3.  A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.

Authors:  E T Tsilou; D Thompson; A S Lindblad; G F Reed; B Rubin; W Gahl; J Thoene; M Del Monte; J A Schneider; D B Granet; M I Kaiser-Kupfer
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 4.  Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.

Authors:  Ekaterini Tsilou; Min Zhou; William Gahl; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

5.  Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.

Authors:  W A Gahl; J A Schneider; J D Schulman; J G Thoene; G F Reed
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

6.  Hemiparesis in a girl with cystinosis and renal transplant.

Authors:  A Van Lierde; D Colombo; L N Rossi; F Marchesi; M Giani; G Consalvo; A Edefonti; L Ghio
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

7.  Growth and pubertal development in nephropathic cystinosis.

Authors:  L Winkler; G Offner; F Krull; J Brodehl
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

8.  Renal transplantation in 22 children with nephropathic cystinosis.

Authors:  J H Ehrich; J Brodehl; D I Byrd; S Hossfeld; P F Hoyer; K P Leipert; G Offner; G Wolff
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 9.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

10.  Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.

Authors:  W W Grody; R M Kern; D Klein; A E Dodson; P B Wissman; S H Barsky; S D Cederbaum
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.